Zhong Ji Longevity Science Group Limited (HKG:0767)
0.4800
0.00 (0.00%)
Sep 11, 2026, 4:08 PM HKT
HKG:0767 Revenue
Zhong Ji Longevity Science Group had revenue of 71.28M HKD in the half year ending June 30, 2026, with 70.20% growth. This brings the company's revenue in the last twelve months to 150.07M, down -13.78% year-over-year. In the year 2025, Zhong Ji Longevity Science Group had annual revenue of 126.10M, down -25.22%.
Revenue (ttm)
150.07M
Revenue Growth
-13.78%
P/S Ratio
2.04
Revenue / Employee
4.84M
Employees
31
Market Cap
305.59M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 126.10M | -42.52M | -25.22% |
| Dec 31, 2024 | 168.63M | 108.84M | 182.06% |
| Dec 31, 2023 | 59.78M | -40.54M | -40.41% |
| Dec 31, 2022 | 100.33M | 18.44M | 22.51% |
| Dec 31, 2021 | 81.89M | 19.38M | 31.01% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| WuXi XDC Cayman | 8.02B |
| Adicon Holdings | 3.06B |
| Kindstar Globalgene Technology | 1.10B |
| Yunkang Group | 624.49M |
| Mega Genomics | 413.73M |
| Biosino Bio-Technology and Science Incorporation | 196.98M |
| King International Investment | 143.23M |
| Guanze Medical Information Industry (Holding) | 98.16M |